9th Annual TPD and Induced Proximity Summit
13 13 people viewed this event.
Accelerating the Clinical Validation of Best-in-Class Degraders and Proximity-Based Drugs to Target the Undruggable
Time: 8:00 am to 5:00 pm
Prices: USD 2699.00 – USD 7295.00
Speakers: Anita Bellail, Chief Executive Officer, HB Therapeutics, Inc, Kara Carter, Chief Executive Officer, Viraccio Therapeutics, Justin Wolfe, Co-Founder and Chief Scientific Officer, Transcera Inc and more
Venue details: Omni Boston Hotel at the Seaport, 450 Summer Street, Boston, Massachusetts, 02210, United States
Event Organizer: Hanson Wade